Zujovic Janko T,Vuletic Milena S,Stojanovic Miroslav,Lazovic Ranko G,Djordjevic Nebojsa P,Radunovic Miodrag L,Jancic Snezana A,Milosevic Velimir S (2021) Clinical significance of proliferation index and E-cadherin expression in colorectal adenocarcinoma, SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, vol. 149, br. 9-10, str. 558-565 (Article) Stojanov Aleksandar,Berisavac Ivana I,Bozovic Ivo,Arsenijevic Mirjana,Lukic-Rajic Sonja,Petrovic Milutin,Stojiljkovic-Tamas Olivera,Jovin Zita B,Djordjevic Gordana M,Jovanovic Dejana R,Stojanovic Miroslav,Martic Vesna V,Basta Ivana Z,Peric Stojan Z (2020) Incidence and mortality rates of Guillain-Barre syndrome in Serbia, JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, vol. 25, br. 4, str. 350-355 (Article) Berisavac Ivana I,Arsenijevic Mirjana,Bozovic Ivo,Mladenovic Branka,Kacar Aleksandra S,Stojiljkovic-Tamas Olivera,Petrovic Milutin,Stojanovic Miroslav,Vujovic Balsa,Martic Vesna V,Jovanovic Dejana R,Lavrnic Dragana V,Basta Ivana Z,Peric Stojan Z (2020) Disability and quality of life in Guillain-Barre syndrome - Longitudinal study, JOURNAL OF CLINICAL NEUROSCIENCE, vol. 78, br. , str. 185-188 (Article) Bjelica Bogdan,Peric Stojan Z,Bozovic Ivo,Kacar Aleksandra S,Opalic Milica,Cobeljic Mina G,Palibrk Aleksa,Stojanov Aleksandar,Petrovic Milutin,Martic Vesna V,Dominovic-Kovacevic Aleksandra,Djordjevic Gordana M,Vukojevic Zoran,Stojanovic Miroslav,Stevic Zorica D,Rakocevic-Stojanovic Vidosava M,Lavrnic Dragana V,Basta Ivana Z (2019) Restless legs syndrome in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), EUROPEAN JOURNAL OF NEUROLOGY, vol. 26, br. , str. 538-538 (Meeting Abstract) Bjelica Bogdan,Bozovic Ivo,Peric Stojan Z,Cobeljic Mina G,Stojanov Aleksandar,Petrovic Milutin,Dejanovic Ivana,Marjanovic Ivan V,Vukojevic Zoran,Dominovic-Kovacevic Aleksandra,Stojanovic Miroslav,Djordjevic Gordana M,Basta Ivana Z (2018) Can we predict development of neuropathic pain in patients with chronic inflammatory demyelinating polyradiculoneuropathy?, JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, vol. 23, br. 4, str. 273-274 (Meeting Abstract) Bjelica Bogdan,Basta Ivana Z,Bozovic Ivo,Kacar Aleksandra S,Nikolic Ana V,Dominovic-Kovacevic Aleksandra,Vukojevic Zoran,Martic Vesna V,Stojanov Aleksandar,Djordjevic Gordana M,Petrovic Milutin,Stojanovic Miroslav,Peric Stojan Z (2018) Employment status of patients with chronic inflammatory demyelinating polyradiculoneuropathy, JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, vol. 23, br. 3, str. 178-182 (Article) Cobeljic Mina G,...,Stojanovic Miroslav,...,Rakocevic-Stojanovic Vidosava M,Lavrnic Dragana V,...,(broj koautora 20) (2018) Influence of diabetes mellitus on chronic inflammatory demyelinating polyradiculoneuropathy, EUROPEAN JOURNAL OF NEUROLOGY, vol. 25, br. , str. 369-369 (Meeting Abstract) Kacar Aleksandra S,Bjelica Bogdan,Bozovic Ivo,Peric Stojan Z,Nikolic Ana V,Cobeljic Mina G,Petrovic Milutin,Stojanov Aleksandar,Djordjevic Gordana M,...,Stojanovic Miroslav,Stevic Zorica D,Rakocevic-Stojanovic Vidosava M,Lavrnic Dragana V,Basta Ivana Z (2018) Neuromuscular disease-specific questionnaire to assess quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy, JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, vol. 23, br. 1, str. 11-16 (Article) Bozovic Ivo,Kacar Aleksandra S,Peric Stojan Z,Nikolic Ana V,Bjelica Bogdan,Cobeljic Mina G,Petrovic Milutin,Stojanov Aleksandar,Djuric Vanja,Stojanovic Miroslav,Djordjevic Gordana M,Martic Vesna V,Dominovic Aleksandra,Vukojevic Zoran,Basta Ivana Z (2017) Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy, JOURNAL OF NEUROLOGY, vol. 264, br. 12, str. 2481-2486 (Article) Arnold Douglas L,...,Stojanovic Miroslav,...,(broj koautora 16) (2016) Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon beta-1a in MS, NEUROLOGY, vol. 87, br. 14, str. 1464-1472 (Article) Cohen Jeffrey,...,Stojanovic Miroslav,...,(broj koautora 18) (2012) Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial, LANCET, vol. 380, br. 9856, str. 1819-1828 (Article) Arnold Douglas L,Brinar Vesna,Cohen Jeffrey,Coles Alasdair,Confavreux Christian,Fisher Elizabeth,Fox Edward,Giovannoni Gavin,Hartung Hans,Havrdova Eva,Selmaj Krzysztof,Weiner Howard,Stojanovic Miroslav,Lake Stephen,Margolin David,Panzara Michael,Compston Alastair (2012) Effect of Alemtuzumab vs. Rebif (R) on Brain MRI Measurements: Results of CARE-MS I, a Phase 3 Study, NEUROLOGY, vol. 78, br. , str. - (Meeting Abstract) Havrdova Eva,Arnold Douglas L,Cohen Jeffrey,Coles Alasdair,Confavreux Christian,Fox Edward,Hartung Hans,Selmaj Krzysztof,Weiner Howard,Brinar Vesna,Giovannoni Gavin,Stojanovic Miroslav,Lake Stephen,Margolin David,Oyuela Pedro,Panzara Michael,Compston Alastair (2012) Infections in Phase 3 Study: Comparison of Alemtuzumab and Rebif (R) Efficacy in Multiple Sclerosis I (CARE-MS I), NEUROLOGY, vol. 78, br. , str. - (Meeting Abstract) Selmaj Krzysztof,Arnold Douglas L,Brinar Vesna,Cohen Jeffrey,Coles Alasdair,Confavreux Christian,Fox Edward,Giovannoni Gavin,Hartung Hans,Havrdova Eva,Stojanovic Miroslav,Weiner Howard,Lake Stephen,Margolin David,Oyuela Pedro,Panzara Michael,Compston Alastair (2012) Incidence of Autoimmunity in a Phase 3 Trial: Comparison of Alemtuzumab and Rebif (R) in Multiple Sclerosis I (CARE-MS I), NEUROLOGY, vol. 78, br. , str. - (Meeting Abstract) Fox Edward,Arnold Douglas L,Brinar Vesna,Cohen Jeffrey,Coles Alasdair,Confavreux Christian,Giovannoni Gavin,Hartung Hans,Havrdova Eva,Selmaj Krzysztof,Stojanovic Miroslav,Weiner Howard,Lake Stephen,Margolin David,Panzara Michael,Compston Alastair (2012) Relapse Outcomes with Alemtuzumab vs. Rebif (R) in Treatment-Naive Relapsing-Remitting Multiple Sclerosis (CARE-MS I): Secondary and Tertiary Endpoints, NEUROLOGY, vol. 78, br. , str. - (Meeting Abstract) Coles Alasdair,Brinar Vesna,Arnold Douglas L,Cohen Jeffrey,Confavreux Christian,Fox Edward,Hartung Hans,Havrdova Eva,Selmaj Krzysztof,Weiner Howard,Giovannoni Gavin,Stojanovic Miroslav,Lake Stephen,Margolin David,Panzara Michael,Compston Alastair (2012) Efficacy and Safety Results from Comparison of Alemtuzumab and Rebif (R) Efficacy in Multiple Sclerosis I (CARE-MS I): A Phase 3 Study in Relapsing-Remitting Treatment-Naive Patients, NEUROLOGY, vol. 78, br. , str. - (Meeting Abstract)